Adage Capital Partners Gp, L.L.C. Ocular Therapeutix, Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,890,177 shares of OCUL stock, worth $42.7 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,890,177
Previous 5,200,000
25.19%
Holding current value
$42.7 Million
Previous $38.1 Million
5.29%
% of portfolio
0.06%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding OCUL
# of Institutions
203Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$157 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$152 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$140 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$92.1 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $844M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...